| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
57,016 |
51,966 |
$4.76M |
| X4011 |
State-specific procedure code |
13,611 |
12,918 |
$3.97M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,929 |
13,581 |
$3.59M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,260 |
14,269 |
$2.94M |
| Y7506 |
|
18,599 |
16,094 |
$2.91M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,030 |
33,531 |
$2.58M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,714 |
12,589 |
$2.49M |
| 80053 |
Comprehensive metabolic panel |
38,266 |
34,790 |
$2.39M |
| X4006 |
|
1,789 |
1,483 |
$1.80M |
| 81001 |
|
17,572 |
16,634 |
$1.34M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,262 |
12,194 |
$1.03M |
| Y7507 |
|
2,491 |
2,209 |
$872K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,536 |
5,085 |
$565K |
| 87400 |
|
1,281 |
1,229 |
$464K |
| 71045 |
Radiologic examination, chest; single view |
6,556 |
6,084 |
$433K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,052 |
5,819 |
$407K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,867 |
2,643 |
$371K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
11,317 |
10,662 |
$353K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,925 |
1,613 |
$295K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,812 |
1,695 |
$286K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,277 |
1,219 |
$269K |
| 84484 |
|
5,490 |
4,911 |
$232K |
| 83690 |
|
8,237 |
7,766 |
$222K |
| 87070 |
|
716 |
699 |
$220K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,318 |
3,197 |
$201K |
| X4003 |
|
1,670 |
1,278 |
$164K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,365 |
1,239 |
$162K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,693 |
529 |
$144K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
457 |
438 |
$136K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,586 |
3,240 |
$110K |
| 81025 |
|
3,913 |
3,660 |
$103K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,514 |
2,371 |
$100K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
328 |
321 |
$98K |
| 83880 |
|
3,036 |
2,877 |
$97K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
731 |
584 |
$94K |
| 20610 |
|
669 |
560 |
$86K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,047 |
967 |
$81K |
| 29580 |
|
1,221 |
574 |
$79K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,752 |
2,446 |
$78K |
| G0378 |
Hospital observation service, per hour |
251 |
224 |
$77K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
25 |
25 |
$77K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,511 |
3,166 |
$76K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,581 |
2,446 |
$72K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
515 |
347 |
$70K |
| 88342 |
|
464 |
364 |
$64K |
| 95117 |
|
1,658 |
919 |
$60K |
| 95115 |
|
1,642 |
913 |
$56K |
| A0425 |
Ground mileage, per statute mile |
2,053 |
1,734 |
$55K |
| 64493 |
|
137 |
105 |
$54K |
| 87807 |
|
360 |
346 |
$48K |
| 77386 |
|
113 |
12 |
$47K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
671 |
579 |
$43K |
| D7999 |
|
12 |
12 |
$39K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
945 |
896 |
$38K |
| 88313 |
|
90 |
87 |
$36K |
| 87040 |
|
151 |
147 |
$35K |
| 87634 |
|
775 |
727 |
$33K |
| 73560 |
|
394 |
336 |
$32K |
| 85610 |
|
500 |
475 |
$32K |
| 64490 |
|
224 |
155 |
$31K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
917 |
852 |
$31K |
| 20611 |
|
238 |
215 |
$30K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
43 |
41 |
$28K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,551 |
1,497 |
$24K |
| 82150 |
|
136 |
126 |
$24K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
218 |
199 |
$23K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
429 |
398 |
$23K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
43 |
38 |
$22K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
955 |
912 |
$22K |
| 71046 |
Radiologic examination, chest; 2 views |
311 |
302 |
$21K |
| 85730 |
|
434 |
409 |
$20K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
204 |
56 |
$20K |
| 93017 |
|
169 |
168 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
1,645 |
1,527 |
$18K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
103 |
102 |
$17K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
38 |
34 |
$17K |
| 90834 |
Psychotherapy, 45 minutes with patient |
239 |
193 |
$16K |
| 95811 |
|
30 |
26 |
$16K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
538 |
522 |
$16K |
| 80061 |
Lipid panel |
1,117 |
1,072 |
$15K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
130 |
121 |
$15K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
41 |
39 |
$15K |
| 99152 |
|
474 |
366 |
$14K |
| 64483 |
|
71 |
53 |
$14K |
| 77336 |
|
159 |
68 |
$14K |
| J3490 |
Unclassified drugs |
1,674 |
1,260 |
$14K |
| 83605 |
|
884 |
833 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
229 |
184 |
$12K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
156 |
155 |
$12K |
| 64494 |
|
52 |
37 |
$11K |
| 73630 |
|
221 |
179 |
$11K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
7,275 |
6,302 |
$11K |
| 95911 |
|
30 |
30 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
80 |
76 |
$9K |
| 83735 |
|
1,443 |
1,357 |
$8K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
346 |
82 |
$8K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
327 |
313 |
$8K |
| 80081 |
|
131 |
128 |
$7K |
| 90837 |
Psychotherapy, 53 minutes with patient |
90 |
82 |
$7K |
| J2704 |
Injection, propofol, 10 mg |
503 |
480 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
183 |
177 |
$6K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
20 |
12 |
$6K |
| 77300 |
|
26 |
24 |
$6K |
| 88341 |
|
122 |
116 |
$6K |
| 77334 |
|
18 |
15 |
$5K |
| 51798 |
|
194 |
190 |
$5K |
| 86850 |
|
13 |
13 |
$5K |
| 88142 |
|
294 |
283 |
$4K |
| 36591 |
|
324 |
193 |
$4K |
| 76801 |
|
13 |
12 |
$4K |
| 85027 |
|
1,344 |
1,266 |
$4K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
77 |
70 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
155 |
150 |
$4K |
| 85379 |
|
24 |
24 |
$3K |
| 87081 |
|
92 |
90 |
$3K |
| 86803 |
|
285 |
272 |
$3K |
| 11056 |
|
103 |
83 |
$3K |
| 64491 |
|
148 |
104 |
$3K |
| 0001A |
|
163 |
125 |
$2K |
| 27096 |
|
48 |
42 |
$2K |
| 0002A |
|
127 |
108 |
$2K |
| 82950 |
|
295 |
258 |
$2K |
| 73562 |
|
39 |
30 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
39 |
36 |
$2K |
| 94060 |
|
15 |
12 |
$2K |
| 92523 |
|
12 |
12 |
$2K |
| 92567 |
|
73 |
72 |
$2K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
14 |
14 |
$2K |
| 97602 |
|
57 |
38 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,011 |
906 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
507 |
468 |
$1K |
| 73030 |
|
43 |
38 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
221 |
209 |
$1K |
| 69210 |
|
52 |
48 |
$1K |
| 83970 |
|
49 |
49 |
$1K |
| 84439 |
|
134 |
132 |
$1K |
| 73564 |
|
14 |
12 |
$988.48 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
71 |
65 |
$956.03 |
| 86780 |
|
87 |
86 |
$946.33 |
| 97161 |
|
49 |
39 |
$943.61 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
57 |
51 |
$924.45 |
| 11721 |
|
135 |
124 |
$911.55 |
| 81002 |
|
318 |
306 |
$889.12 |
| 80069 |
|
171 |
160 |
$855.62 |
| 82728 |
|
87 |
86 |
$850.29 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
24 |
24 |
$822.60 |
| 72170 |
|
14 |
12 |
$743.88 |
| 87186 |
|
98 |
92 |
$598.37 |
| 84481 |
|
27 |
27 |
$582.51 |
| 83550 |
|
88 |
87 |
$558.41 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
431 |
396 |
$502.90 |
| 0012A |
|
49 |
48 |
$469.80 |
| 83655 |
|
26 |
26 |
$456.74 |
| 83540 |
|
88 |
87 |
$412.79 |
| 87088 |
|
67 |
61 |
$314.85 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
90 |
76 |
$302.14 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12 |
12 |
$288.97 |
| 87077 |
|
61 |
61 |
$251.09 |
| 82747 |
|
15 |
15 |
$248.69 |
| 84702 |
|
15 |
12 |
$216.15 |
| 86140 |
|
62 |
60 |
$192.93 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
15 |
$171.04 |
| 84460 |
|
50 |
50 |
$138.58 |
| 11720 |
|
90 |
82 |
$123.96 |
| 86706 |
|
13 |
13 |
$121.39 |
| 0011A |
|
17 |
17 |
$88.40 |
| 80076 |
|
12 |
12 |
$62.70 |
| 82570 |
|
17 |
17 |
$51.83 |
| 85007 |
|
26 |
24 |
$41.96 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
25 |
25 |
$41.55 |
| 85018 |
|
27 |
27 |
$35.43 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13 |
12 |
$33.40 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
62 |
45 |
$22.43 |
| 11719 |
|
16 |
14 |
$17.99 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
67 |
65 |
$4.94 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
14 |
14 |
$3.25 |
| 85014 |
|
12 |
12 |
$2.13 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
57 |
47 |
$1.61 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
61 |
59 |
$0.60 |
| A9270 |
Non-covered item or service |
131 |
95 |
$0.00 |
| 95886 |
|
18 |
18 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
12 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
29 |
25 |
$0.00 |